CRISM Therapeutics Corporation Asset Resilience Ratio

Latest as of December 2023: 19.75%

CRISM Therapeutics Corporation asset resilience ratio. CRISM Therapeutics Corporation (CRTX) has an Asset Resilience Ratio of 19.75% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CRISM Therapeutics Corporation defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

GBX945.03K

≈ $114.98 USD Cash + Short-term Investments

Total Assets

GBX4.79 Million

≈ $582.32 USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of CRISM Therapeutics Corporation (2009–2014)

Asset resilience ratio of CRISM Therapeutics Corporation from 2009 to 2014. This chart shows how CRISM Therapeutics Corporation's Asset Resilience Ratio has changed over time. Read CRTX total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down CRISM Therapeutics Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of CRISM Therapeutics Corporation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX945.03K	19.75%
Total Liquid Assets	GBX945.03K	19.75%

Asset Resilience Insights

Good Liquidity Position: CRISM Therapeutics Corporation maintains a healthy 19.75% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

CRISM Therapeutics Corporation Industry Peers by Asset Resilience Ratio

Compare CRISM Therapeutics Corporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

CRISM Therapeutics Corporation Asset Resilience Ratio by Year (2009–2014)

CRISM Therapeutics Corporation asset resilience ratio by year from 2009 to 2014. The table below shows the annual Asset Resilience Ratio data for CRISM Therapeutics Corporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2014-12-31	22.41%	GBX4.73 Million ≈ $575.95	GBX21.12 Million ≈ $2.57K	-22.97pp
2013-12-31	45.37%	GBX8.22 Million ≈ $1.00K	GBX18.13 Million ≈ $2.21K	+23.38pp
2012-12-31	21.99%	GBX3.56 Million ≈ $433.17	GBX16.19 Million ≈ $1.97K	+15.94pp
2011-12-31	6.05%	GBX1.29 Million ≈ $156.66	GBX21.29 Million ≈ $2.59K	-5.31pp
2010-12-31	11.36%	GBX2.43 Million ≈ $295.77	GBX21.40 Million ≈ $2.60K	+8.81pp
2009-12-31	2.55%	GBX427.90K ≈ $52.06	GBX16.81 Million ≈ $2.05K	--

pp = percentage points

About CRISM Therapeutics Corporation

LSE:CRTX UK Biotechnology

Market Cap

$84.30K

GBX692.87 Million GBX

Market Cap Rank

#31584 Global

#1137 in UK

Share Price

GBX8.75

Change (1 day)

+0.00%

52-Week Range

GBX8.75 - GBX17.50

All Time High

GBX2425.08